Sinomenine inhibits the expression of PD‑L1 in the peripheral blood mononuclear cells of mesangial proliferative nephritis patients

Cheng,Yue; Li,Furong; Wang,Daihong; Zhang,Ying; Yuan,Fahuan; Zhang,Jingbo

doi:10.3892/mmr.2013.1302

Sinomenine inhibits the expression of PD‑L1 in the peripheral blood mononuclear cells of mesangial proliferative nephritis patients

Authors:
- Yue Cheng
- Furong Li
- Daihong Wang
- Ying Zhang
- Fahuan Yuan
- Jingbo Zhang
View Affiliations

Affiliations: Department of Nephrology, Xinqiao Hospital, Third Military Medical University, PLA, Chongqing 400037, P.R. China
Published online on: February 1, 2013 https://doi.org/10.3892/mmr.2013.1302
Pages: 1223-1228

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Sinomenine has been used to treat autoimmune diseases for centuries. However, little is known about its exact mechanisms of action. Whether sinomenine has an effect on programmed death‑1 (PD‑1) ligands (PD‑Ls) in vivo remains unclear. The present study aimed to determine the effect of sinomenine on the expression of PD‑L1 and PD‑L2 in peripheral blood mononuclear cells (PBMCs). A total of 25 patients with mesangial proliferative nephritis (MsPGN) were treated with sinomenine and followed up for 3 months. The expression of PD‑L1 and PD‑L2 was studied by using real‑time RT‑PCR and flow cytometric analysis, and recorded at months 0, 1 and 3 within the PBMCs. The intra‑renal expression of PD‑L1 and PD‑L2 was studied by immunohistochemistry. The results revealed that the PBMCs from the MsPGN patients expressed high levels of PD‑L1 at the mRNA and protein levels compared with the healthy donors. Immunohistochemistry revealed an increased PD‑L1 expression in the renal tissues from the MsPGN patients. Sinomenine was observed to have a significant effect in decreasing the PD‑L1 expression in the PBMCs. The present study therefore suggests a novel mechanism for the therapeutic effects of sinomenine on MsPGN in vivo.

View Figures

View References

1	Yamasaki H: Pharmacology of sinomenine, an anti-rheumatic alkaloid from Sinomenium acutum. Acta Med Okayama. 30:1–20. 1976.PubMed/NCBI
2	Deng ZS, Zhao Y, He CC, Jin J, He YM and Li JX: pH-dependent, stereoselective dimerization of sinomenine. Org Lett. 10:3879–3882. 2008. View Article : Google Scholar : PubMed/NCBI
3	Zhou H, Wong YF, Wang J, Cai X and Liu L: Sinomenine ameliorates arthritis via MMPs, TIMPs, and cytokines in rats. Biochem Biophys Res Commun. 376:352–357. 2008. View Article : Google Scholar : PubMed/NCBI
4	Dai YB, Huang X, Luo ZG, Li JF, Ou YG, Yang P and Qin JP: Immunosuppressive effect of Sinomenine on ICAM-1 expression in rat renal allograft rejection. Mod J Integr Tradit Chin West Med. 12:1358–1363. 2003.
5	Yang P, Yang L and Luo Z: Effects of sinomenine on T lymphocyte subsets in rat renal allograft transplantation model. J Clin Urol. 18:620–622. 2003.
6	Feng H, Yamaki K, Takano H, Inoue K, Yanagisawa R and Yoshino S: Effect of sinomenine on collagen-induced arthritis in mice. Autoimmunity. 40:532–539. 2007. View Article : Google Scholar : PubMed/NCBI
7	Cohen RA, Bayliss G, Crispin JC, Kane-Wanger GF, Van Beek CA, Kyttaris VC, Avalos I, Yu CY, Tsokos GC and Stillman IE: T cells and in situ cryoglobulin deposition in the pathogenesis of lupus nephritis. Clin Immunol. 128:1–7. 2008. View Article : Google Scholar : PubMed/NCBI
8	Kurts C, Heymann F, Lukacs-Kornek V, Boor P and Floege J: Role of T cells and dendritic cells in glomerular immunopathology. Semin Immunopathol. 29:317–335. 2007. View Article : Google Scholar : PubMed/NCBI
9	Baxter AG and Hodgkin PD: Activation rules: the two-signal theories of immune activation. Nat Rev Immunol. 2:439–446. 2002.PubMed/NCBI
10	Goronzy JJ and Weyand CM: T-cell co-stimulatory pathways in autoimmunity. Arthritis Res Ther. 10(Suppl 1): S32008. View Article : Google Scholar
11	Loisel-Meyer S, Foley R and Medin JA: Immuno-gene therapy approaches for cancer: from in vitro studies to clinical trials. Front Biosci. 13:3202–3214. 2008. View Article : Google Scholar : PubMed/NCBI
12	Korman A, Yellin M and Keler T: Tumor immunotherapy: preclinical and clinical activity of anti-CTLA4 antibodies. Curr Opin Investig Drugs. 6:582–591. 2005.PubMed/NCBI
13	Nishimura H, Okazaki T, Tanaka Y, Nakatani K, Hara M, Matsumori A, Sasayama S, Mizoguchi A, Hiai H, Minato N and Honjo T: Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice. Science. 291:319–322. 2001. View Article : Google Scholar : PubMed/NCBI
14	Fife BT, Pauken KE, Eagar TN, Obu T, Wu J, Tang Q, Azuma M, Krummel MF and Bluestone JA: Interactions between PD-1 and PD-L1 promote tolerance by blocking the TCR-induced stop signal. Nat Immunol. 10:1185–1192. 2009. View Article : Google Scholar : PubMed/NCBI
15	Latchman YE, Liang SC, Wu Y, Chernova T, Sobel RA, Klemm M, Kuchroo VK, Freeman GJ and Sharpe AH: PD-L1-deficient mice show that PD-L1 on T cells, antigen-presenting cells, and host tissues negatively regulates T cells. Proc Natl Acad Sci USA. 101:10691–10696. 2004. View Article : Google Scholar : PubMed/NCBI
16	Dong H, Zhu G, Tamada K and Chen L: B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion. Nat Med. 5:1365–1369. 1999. View Article : Google Scholar : PubMed/NCBI
17	Subudhi SK, Zhou P, Yerian LM, Chin RK, Lo JC, Anders RA, Sun Y, Chen L, Wang Y, Alegre ML and Fu YX: Local expression of B7-H1 promotes organ-specific autoimmunity and transplant rejection. J Clin Invest. 113:694–700. 2004. View Article : Google Scholar : PubMed/NCBI
18	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2[-Delta Delta C(T)] method. Methods. 25:402–408. 2001.
19	Chen Y, Zhang J, Li J, Zou L, Zhao T, Tang Y and Wu Y: Expression of B7-H1 in inflammatory renal tubular epithelial cells. Nephron Exp Nephrol. 102:81–92. 2006. View Article : Google Scholar : PubMed/NCBI
20	Cheng Y, Zhang J, Hou W, Wang D, Li F, Zhang Y and Yuan F: Immunoregulatory effects of sinomenine on the T-bet/GATA-3 ratio and Th1/Th2 cytokine balance in the treatment of mesangial proliferative nephritis. Int Immunopharmacol. 9:894–899. 2009. View Article : Google Scholar : PubMed/NCBI
21	del Rio ML, Buhler L, Gibbons C, Tian J and Rodriguez-Barbosa JI: PD-1/PD-L1, PD-1/PD-L2, and other co-inhibitory signaling pathways in transplantation. Transpl Int. 21:1015–1028. 2008.PubMed/NCBI
22	Menke J, Lucas JA, Zeller GC, Keir ME, Huang XR, Tsuboi N, Mayadas TN, Lan HY, Sharpe AH and Kelley VR: Programmed death 1 ligand (PD-L) 1 and PD-L2 limit autoimmune kidney disease: distinct roles. J Immunol. 179:7466–7477. 2007. View Article : Google Scholar : PubMed/NCBI
23	Tamura H, Dong H, Zhu G, Sica GL, Flies DB, Tamada K and Chen L: B7-H1 costimulation preferentially enhances CD28-independent T-helper cell function. Blood. 97:1809–1816. 2001. View Article : Google Scholar : PubMed/NCBI
24	Kanai T, Totsuka T, Uraushihara K, et al: Blockade of B7-H1 suppresses the development of chronic intestinal inflammation. J Immunol. 171:4156–4163. 2003. View Article : Google Scholar : PubMed/NCBI
25	Shu L, Yin W, Zhang J, Tang B, Kang YX, Ding F and Hua ZC: Sinomenine inhibits primary CD4⁺ T-cell proliferation via apoptosis. Cell Biol Int. 31:784–789. 2007. View Article : Google Scholar : PubMed/NCBI
26	He X, Wang J, Guo Z, Liu Q, Chen T, Wang X and Cao X: Requirement for ERK activation in sinomenine-induced apoptosis of macrophages. Immunol Lett. 98:91–96. 2005. View Article : Google Scholar : PubMed/NCBI
27	Wang Y, Fang Y, Huang W, Zhou X, Wang M, Zhong B and Peng D: Effect of sinomenine on cytokine expression of macrophages and synoviocytes in adjuvant arthritis rats. J Ethnopharmacol. 98:37–43. 2005. View Article : Google Scholar : PubMed/NCBI
28	Tu S, Hu Y and Lu F: Effect of Sinomenine on IL-8, IL-6, IL-2 produced by peripheral blood mononuclear cells. J Tongji Med Univ. 19:257–259. 1999. View Article : Google Scholar : PubMed/NCBI
29	Huang QC, Chen JF, Chen GX, et al: Effect of sinomenine on apoptosis of synoviocytes in CIA rats. Zhongguo Lin Chuang Kang Fu. 6:2541–2548. 2002.(In Chinese).
30	Zhao Y, Li J, Yu K, Liu Y and Chen X: Sinomenine inhibits maturation of monocyte-derived dendritic cells through blocking activation of NF-kappa B. Int Immunopharmacol. 7:637–645. 2007. View Article : Google Scholar : PubMed/NCBI